| Authors: |
Alexander SPH; Division of Physiology, Pharmacology and Neuroscience, Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom. Electronic address: steve.alexander@nottingham.ac.uk., Bennett KA; Nxera Pharma UK Ltd, Cambridge, United Kingdom., Brown AJ; Ikherma Consulting Ltd, Hertfordshire, United Kingdom., Glass M; School of Pharmacy and Pharmacology, University of Otago, Otago, New Zealand., Gloriam DE; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Hanson J; Laboratory of Molecular Pharmacology, GIGA Research Institute and Center of Interdisciplinary Research on Medicine, University of Liège, Liège, Belgium., Insel PA; Departments of Pharmacology and Medicine, University of California, San Diego, La Jolla, California., Kelly E; School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom., Langmead CJ; Drug Discovery Biology and Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Martemyanov KA; Department of Physiology and Biophysics, University of Miami Miller School of Medicine, Miami, Florida., Neubig RR; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan and Nicholas V. Perricone, MD, Division of Dermatology, Department of Medicine, College of Human Medicine, East Lansing, Michigan., Offermanns S; Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim Germany and Center for Molecular Medicine, Goethe-University Frankfurt, Frankfurt am Main, Germany., Rosenkilde MM; Department of Biomedical Sciences, Lab for Molecular Pharmacology, University of Copenhagen, Copenhagen, Denmark., Schulte G; Department Physiology and Pharmacology, Section of Receptor Biology and Signaling, Karolinska Institutet, Stockholm Sweden., Smith NJ; Orphan Receptor Laboratory, Department of Pharmacology, School of Biomedical Sciences, Faculty of Medicine & Health, UNSW Sydney, Sydney, Australia., Wu H; Medicine Design, Pfizer Research and Development, Pfizer Inc, Groton, Connecticut., Faccenda E; Institute for Neuroscience and Cardiovascular Research, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom., Harding SD; Institute for Neuroscience and Cardiovascular Research, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom., Davenport AP; Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Level 6, Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, United Kingdom. |
